Kalaris Therapeutics (KLRS) Assets (2019 - 2026)
Kalaris Therapeutics (KLRS) recorded Assets of $99.54 million in Q2 2026, up 7.2% from $92.84 million a year earlier but down 9.3% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Kalaris Therapeutics reported Assets of $121.74 million.
- Annual Assets has a five-year compound annual growth rate of -20.0% (FY2020 to FY2025).
- Across earlier years, Assets came in at $6.16 million in FY2024 (-96.8%), $190.8 million in FY2023 (-31.1%), $277.08 million in FY2022 (-3.3%) and $286.59 million in FY2021 (-22.7%).
- Quarterly Assets has ranged from $6.16 million in Q4 2024 to $316.53 million in Q3 2021 over the past five years.
- On a year-over-year basis, Assets rose in two of the last seven quarters, with an average decline of 32.2%.
- Peak year-over-year performance for Assets in the last five years was growth of 41.3% in Q2 2023, against a decline of 96.8% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $109.81 million (Q1 2026), $121.74 million (Q4 2025) and $81.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Kalaris Therapeutics | 67.84 Mn | 67.84 Mn | - | 99.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.54 Mn |
| Mar 31, 2026 | 109.81 Mn |
| Dec 31, 2025 | 121.74 Mn |
| Sep 30, 2025 | 81.18 Mn |
| Jun 30, 2025 | 92.84 Mn |
| Mar 31, 2025 | 103.09 Mn |
| Dec 31, 2024 | 6.16 Mn |
| Sep 30, 2024 | 122.53 Mn |
| Jun 30, 2024 | 130.99 Mn |
| Mar 31, 2024 | 144.14 Mn |
| Dec 31, 2023 | 190.80 Mn |
| Sep 30, 2023 | 248.31 Mn |
| Jun 30, 2023 | 282.69 Mn |
| Mar 31, 2023 | 244.04 Mn |
| Dec 31, 2022 | 277.08 Mn |
| Sep 30, 2022 | 293.70 Mn |
| Jun 30, 2022 | 200.00 Mn |
| Mar 31, 2022 | 231.09 Mn |
| Dec 31, 2021 | 286.59 Mn |
| Sep 30, 2021 | 316.53 Mn |
API Access
Kalaris Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();